# Epican

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/epican

- Industry: Healthcare
- Headquarters: Shanghai, China
- Website: www.jollian.cn
- Total disclosed funding: $5.3M
- Latest round: Series B (Dec 20, 2017)
- Investors on record: 2

## About

Based in Shanghai, and established in 2015, Epican is a healthcare company that focuses on the R&D, production, and service of genetic diagnosis products. The company doing business used the name of Zaoyian. The company's founder is professor Chuan He at Chicago University, who majored in gene epigenetic testing technology. The company has 9 patents, including 7 USA patents. Moreover, the company has undertaken infectious disease prevention and control projects, such as AIDS, and hepatitis.    

The company developed cancer early diagnosis products that can detect cancer including liver cancer, stomach cancer, intestine cancer, and esophagus cancer by drawing 8mL of blood. The processes used the technology of gene sequencing, chemical label capture, machine learning, and big data.

## Funding rounds

- Series B, Dec 20, 2017 — Comway Capital
- Series A, Jul 6, 2016, $5.3M — Viva Ventures Biotech

## Investors

- Viva Ventures Biotech (https://capitalatlas.ai/funds/viva-ventures-biotech) — Series A
- Comway Capital (https://capitalatlas.ai/funds/comway-capital) — Series B